Contineum Therapeutics (CTNM) Cash from Operations (2023 - 2026)

Contineum Therapeutics' Cash from Operations history runs 4 years deep, the most recent figure standing at 16266000.0 for Q1 2026.

• In Q1 2026, Cash from Operations fell 12.86% year-over-year to 16266000.0; the TTM figure through Mar 2026 stood at 57166000.0 (down 45.53% YoY), while the FY2025 annual figure was 55312000.0, down 68.4% from the prior year.
• Cash from Operations was 16266000.0 for Q1 2026 at Contineum Therapeutics, down from 13042000.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 40674000.0 in Q2 2023 to a low of 16266000.0 in Q1 2026.
• Historically, Cash from Operations has averaged 6544153.85 across 4 years, with a median of 10202000.0 in 2024.
• Biggest YoY gain for Cash from Operations was 4.69% in 2024; the steepest drop was 120.9% in 2024.
• A 4-year view of Cash from Operations shows it stood at 10704000.0 in 2023, then increased by 4.69% to 10202000.0 in 2024, then dropped by 27.84% to 13042000.0 in 2025, then decreased by 24.72% to 16266000.0 in 2026.
• The last three Cash from Operations figures came in at 16266000.0 (Q1 2026), 13042000.0 (Q4 2025), and 12197000.0 (Q3 2025), per Business Quant data.